Tech consultancy firm Accenture specialises in analysing the healthcare sector's adoption of new technologies. We speak to its head of global practice, Kaveh Safavi, to find out more.
A recent study in the Lancet showed that it was more dangerous to have access to poor quality health care than to have no access to health care. That is particularly true in Emerging Markets where quality varies dramatically. Julia Khalimova, Healthcare Quality and Patient Safety Specialist at IFC, the arm of the World Bank that invests in the private sectors of emerging markets, has been studying the field for ten years and IFC has recently launched a tool to enable operators to measure and improve. We talk to her about the problem. What progress has been made? And what is the best solution?
"Health care services is a dirty enough business in Europe without us seeking more risk in Emerging Markets" was how a big private equity investor summed up his sentiment.
Value health is the revolutionary idea pioneered by Harvard guru Michael Porter. He had the temerity to suggest providers should be rewarded for quality, rather than activity and that the patient should be viewed and consulted as customers. Invented in the early noughties, it hit a high water mark 7-8 years ago when Obamacare was rolled out incorporating the concept. Then it felt like an inexorable river.
One of South Africa's largest acute care groups is piloting a nurse-led, bricks and mortar but digitally managed, primary care model based in a retail unit. Confused? HBI speaks to group operations executive, Tanya Little, at Life Healthcare to find out more.
We examine a feast of data, the 2018 results, from Cerba, Synlab and Unilabs and contrast them with Sonic and Eurofins. What do they tell us about their performance across routine lab testing, acquisitions and diversification?
HBI reports from the Sub-Saharan Africa panel at HBI 2019, where Teo Sarda, CEO of Sphera, Dr Shrey Viranna, CEO of Life, and Audrey Obara, head of healthcare for Swedfund, talked about how to sustainably invest in Africa.
HBI hears of plans to build a substantial pan-African private hospital chain with an announcement expected as early as 2019. It would be the first investor to attempt this since now-defunct private equity firm Abraaj.
Credit funds and whopping piles of dry powder ($1.8trn in 2018) should save the sector from a valuation crash despite general market underperformance and a dire macro economic backdrop, said Hedley Goldberg, partner at Rothschild at HBI 2019.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
